NASDAQ:AARD | Free Cash Flow | Aardvark Therapeutics, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2024-03-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$18.87M
2025-12-31-$16.81M$0.00-$16.81M
2025-03-31-$11.39M$0.00-$11.39M
2024-12-31-$7.73M$6,000.00-$7.73M
2024-03-31-$2.19M$5,000.00-$2.2M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$54.17M$95,000.00-$54.27M
2024-12-31-$18.09M$109,000.00-$18.2M